MKI67 and breast cancer: Shaaban and colleagues [28], along with several other reports [29,30], suggested that benign breast lesions such as epithelial hyperplasia, when associated with increased levels of Ki-67 and estrogen receptors type A, define a subset of hyperplastic lesions with high risk of subsequent breast cancer development.